Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a huge burden of kidney healthcare costs among black people all over the ...

Q4 2024 Management View CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

High blood pressure is a major risk factor for heart disease. Here are some common questions you may have about blood ...

High blood pressure, or hypertension, is the leading cause of global mortality and cardiovascular disease. While there is no ...

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...